Karo Pharma AB (publ) carries a market capitalization of 1.52B, placing it among publicly traded companies globally.
| Market Cap | 1.52B |
| Enterprise Value | N/A |
Karo Pharma AB (publ)'s stock has declined approximately -8.03833% over the past 52 weeks. The 50-day moving average sits at 5.25, while the 200-day moving average is 5.25.
| Beta (5Y) | N/A |
| 52-Week Price Change | -8.03833% |
| 50-Day Moving Average | 5.25 |
| 200-Day Moving Average | 5.25 |
| Average Volume (20 Days) | N/A |
Karo Pharma AB (publ)'s most recent stock split took place on August 26, 2015 with a 20:1 split ratio.
| Last Split Date | 8/26/2015 |
| Split Ratio | 20:1 |